Cite

HARVARD Citation

    Nash, P. et al. (2022). Upadacitinib as monotherapy and in combination with non-biologic disease-modifying antirheumatic drugs for psoriatic arthritis. Rheumatology. pp. 3257-3268. [Online]. 
  
Back to record